EXELIXIS, INC. — Director's Dealing 2020

Feb 22, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2020-02-19

Reporting Person: Schwab Gisela (Pres, Prod Dev & Med Aff & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-19	Common Stock	M	40000	$5.51	Acquired	365122	Direct
2020-02-19	Common Stock	S	40000	$21.50	Disposed	325122	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-19	Option (right to buy)	$5.51	M	40000	Disposed	2020-09-17	Common Stock (40000.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14880	Indirect

Footnotes

F1: Includes 55,494 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2020.

F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 19, 2020.

F4: The option, representing the right to purchase a total of 240,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017.